Topic Cardioversion

Viewing 1–1 of 1

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Implementation of a Procainamide-Based Cardioversion Strategy for the Management of Recent Onset Atrial Fibrillation
Price: $21.95
Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: AENJ0721A

Published: Jul/Sep 2021

Expires: 3/7/2025

Sources: Advanced Emergency Nursing Journal
Details

Required Passing Score: 8/10 (80%)

Authors: Andrew J. Matuskowitz, MD; Kyle A. Weant, PharmD, BCPS, BCCCP, FCCP; Haili Gregory, PharmD, BCPS; Michael E. Field, MD; Chara Calhoun, PharmD, BCPS; Brent J. Bushkar, MD; Gregory A. Hall, MD; Jeffrey Caporossi, MD

Collections: Acute Care Adult/Gerontology Nurse Practitioner Subscription , CESaver , Cardiac Nursing (Adult) Subscription

Categories: Acute Care , Advanced Practice Nursing , Cardiovascular , Emergency Care , Medical-Surgical

Specialties: Acute Care, Advanced Practice Nursing, Cardiology, Emergency, Interventional Cardiology, Medical-Surgical

Topics: Arrhythmia , Atrial Fibrillation , Cardioversion , Procainamide

Media:

Viewing 1–1 of 1

CEConnection